Rengquijo, Athlestan .
HRN: 23-96-04 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/11/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/11/2025
11/18/2025
IVTT
450mg
Q6h
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes